Remove Insulin Remove Licensing Remove Marketing Remove Packaging
article thumbnail

GLP1 Receptor Agonist Market: Current Landscape, Growth Opportunities and Future Market Outlook

Roots Analysis

GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. GLP-1 Receptor Agonist Market – Current Landscape Presently, more than 150 GLP-1 drug candidates have been commercialized / being developed by more 55 developers to treat various metabolic disorders.

article thumbnail

Provention Bio Launches Campaigns for Familial Type 1 Diabetes Screening

XTalks

Autoantibody screening involves measuring levels of islet autoantibodies (iAb) that recognize antigens found in insulin-producing pancreatic beta cells. She said that’s why it’s “so important that we educate the market with campaigns like the ones we’ve launched.”

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 Pfizer Inc.

Sales 98
article thumbnail

Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance

The Pharma Data

. – Second-quarter 2021 operating expenses increased 18 percent, driven primarily by higher research and development investments for late-stage assets, as well as higher relative marketing and selling expenses due to pandemic-related spending reductions in 2020. – Second-quarter 2021 earnings per share (EPS) decreased to $1.53

article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. Robin welcome to the Pharma marketing podcast and thanks for joining us today. 009 – Robin Farmanfarmaian Podcast Transcript.

Insulin 52
article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. Robin welcome to the Pharma marketing podcast and thanks for joining us today. 009 – Robin Farmanfarmaian Podcast Transcript.

Insulin 52
article thumbnail

(1) Every Morning 12,342+ People Use This "3-Letter Timing Hack" That 92% of Women Have No Idea Exists

The Pharma Data

That’s why you’re making the right choice by ordering your discount package of LumaSlim on the next page…. Just order your discount package on the next page now… Still here? Your ‘Fat Burning Switch’ can’t be activated in the presence of insulin. By far, the most popular order for new customers is the 4-bottle package.